¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"data acquisition time"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® coagulation time ÇÑ±Û ÀÀ°í½Ã°£
¼³¸í   
  Ç÷¾×ÀÀ°í¶õ ÁöÇ÷ÀÇ ÇÑ °úÁ¤À¸·Î ¼¶À¯¼Ò¶õ ¹°ÁúÀ» ¸¸µé¾î ³»´Â °úÁ¤ÀÌ´Ù. ÀÌ ¼¶À¯¼Ò¶õ ¹°ÁúÀº ¼Õ»óµÈ Ç÷°üÀÇ ºÎÀ§¿¡ ÀÛ¿ëÇÏ¿© ¿©·¯ °¡Áö ¼¼Æ÷µéÀ» ¾ô¾î ¹­´Â ¿ªÇÒÀ» ÇÏ¿© °á±¹ ¼Õ»óµÈ Ç÷°ü¿¡¼­ Ç÷¾×ÀÇ ¼Ò½ÇÀ» ¸·´Â´Ù. Ç÷¾×ÀÀ°í´Â ´ÙÀ½°ú °°Àº 3´Ü°è·Î ÀÌ·ç¾îÁø´Ù.
  
  Ã¹¹øÂ° ´Ü°è´Â Ç÷°ü¼Õ»ó¿¡ ÀÇÇØ¼­ prothrombin activator¶ó´Â °ÍÀÌ ¸¸µé¾îÁö´Â ´Ü°èÀÌ´Ù. µÎ¹øÂ° ´Ü°è´Â ÀÌ prothrombin activator¶ó´Â ¹°Áú¿¡ ÀÇÇØ¼­ Ç÷¾×¼Ó¿¡ Àִ ÇÁ·ÎÆ®·ÒºóÀ̶ó´Â ¹°ÁúÀÌ Æ®·ÒºóÀ̶ó´Â ¹°Áú·Î ¹Ù²î´Â ´Ü°èÀÌ´Ù. ¼¼¹øÂ° ´Ü°è´Â Æ®·ÒºóÀ̶ó´Â ¹°Áú¿¡ ÀÇÇØ¼­ ¼¶À¯¼Ò¿øÀ̶ó´Â ¹°ÁúÀÌ ¼¶À¯¼ÒÀ¸·Î ¹Ù²î´Â ´Ü°èÀÌ´Ù.
  
  ÀÀ°íÀÛ¿ëÀº Å©°Ô 2°¡Áö·Î ³ª´µ´Âµ¥, ¿ÜÀμº ÀÀ°íÀÎÀÚ¿Í ³»Àμº ÀÀ°íÀÎÀÚ°¡ ±×°ÍÀÌ´Ù. ¿ÜÀμº ÀÀ°íÀÎÀÚ¿Í ³»Àμº ÀÀ°íÀÎÀڴ °¢±â º°°³·Î ÀÛ¿ëÇÏÁö¸¸, °á±¹Àº ¸¶Áö¸· °úÁ¤¿¡¼­ Çϳª·Î ¸¸³ª¼­ ¼¶À¯¼Ò¿øÀ» ¼¶À¯¼Ò(ÀÀ°íÀÛ¿ëÀÇ ¸¶Áö¸· ´Ü°è¿¡ »ý¼ºµÇ¸ç ´Ü´ÜÇϰí Ç®¸®Áö ¾Ê´Â ¸ÅµìÀ» Çü¼ºÇÏ¿© ÁöÇ÷ÀÛ¿ëÀ» ¿Ï¼ºÇÑ´Ù)À¸·Î ¸¸µé¾î ÀÀ°íÀÛ¿ëÀ» ³ªÅ¸³½´Ù.
¿µ¹® bleeding time ÇÑ±Û ÃâÇ÷½Ã°£
¼³¸í   
  ¸ö¿¡ »óó°¡ ³ª¼­ ÃâÇ÷ÀÌ ÀÖ¾úÀ» °æ¿ì¿¡ Çǰ¡ ¸Ü´Âµ¥ ±îÁö °É¸®´Â ½Ã°£À» ÃâÇ÷½Ã°£À̶ó°í ÇÑ´Ù. »ç¶÷ÀÇ ¸ö¿¡ »óó°¡ ³ª¼­ ÃâÇ÷ÀÌ ÀÖÀ» °æ¿ì¿¡ À̰ÍÀ» ¸·°í ÇǸ¦ ´õÀ̻󠳪Áö ¾Ê°Ô Çϴ °ÍÀ» ÁöÇ÷À̶ó°í ÇÑ´Ù. ÁöÇ÷ÀÇ °úÁ¤¿¡´Â Å©°Ô µÎ °¡Áö ´Ü°è°¡ ÀÖ´Ù. Ã¹¹øÂ° ´Ü°è´Â Ç÷¼ÒÆÇµéÀÌ »óó°¡ ³ª¼­ ¼Õ»óµÈ Ç÷°üÀÇ ºÎÀ§¸¦ ¸·´Â °ÍÀÌ´Ù. ÀÌ·¸°Ô Çϸ頿켱 Ç÷°üÀÇ ¼Õ»óºÎÀ§·ÎºÎÅÍ Çǰ¡ ³ª¿À´Â °ÍÀ» ¸·À» ¼ö°¡ ÀÖ´Ù. ´ÙÀ½ÀÇ ´Ü°è´Â »ó󸦠¸·°í Àִ Ç÷¼ÒÆÇÀ§¿¡ ¿©·¯ °¡Áö ¹°ÁúµéÀÌ ÀÛ¿ëÇØ¼­ ´õ¿í ´Ü´ÜÇϰԠÇÏ¿© »óó°¡ ³­ Ç÷°ü¿¡¼­ Çǰ¡ »õ´Â °ÍÀ» ¿µ±¸È÷ ¸·´Â °ÍÀÌ´Ù. ½±°Ô ¸»Çϸé Ç÷¼ÒÆÇÀº º®µ¹¿¡ ÇØ´çÇϴ °ÍÀÌ°í µÎ¹øÂ° °úÁ¤¿¡ Âü¿©Çϴ ¹°ÁúµéÀº ½Ã¸àÆ®¿¡ ÇØ´çÇϴ °ÍÀÌ´Ù. ÀÌ µÎ °úÁ¤ÀÌ ¿ÏÀüÇÒ °æ¿ì¿¡ ÁöÇ÷ÀÌ ¼øÁ¶·Ó°Ô ÀϾ´Ù.
  
  ÃâÇ÷½Ã°£Àº À§¿¡¼­ ¼³¸íÇÑ ÁöÇ÷ÀÇ µÎ°¡Áö °úÁ¤ Áß¿¡¼­ Ã¹¹øÂ° °úÁ¤¿¡ ÀÇÇØ¼­¸¸ ¿µÇâÀ» ¹Þ´Â´Ù. Áï ¼Õ»óµÈ Ç÷°üÀ» ¸·¾ÆÁִ º®µ¹¿¡ ÇØ´çÇϴ Ç÷¼ÒÆÇÀÇ ±â´É¸¸ Á¤»óÀÏ °æ¿ì¿¡ ÃâÇ÷½Ã°£Àº Á¤»óÀ¸·Î ³ª¿Â´Ù. ¸¸¾à Ç÷¼ÒÆÇÀÇ ±â´É¿¡ ÀÌ»óÀÌ Àִ °æ¿ì¿¡´Â ÀÚ¿¬È÷ ÃâÇ÷½Ã°£ÀÌ ±æ¾îÁø´Ù.
¿µ¹® prothrombin time ÇÑ±Û ÇÁ·ÎÆ®·Òºó½Ã°£
¼³¸í   
  ÇÁ·ÎÆ®·ÒºóÀº °£¿¡¼­ ÇÕ¼ºµÇ´Â ºñŸ¹Î K ÀÇÁ¸¼º ÀÀ°í´Ü¹éÁúÀÇ ÇϳªÀ̸ç, ÇÁ·ÎÆ®·Òºó½Ã°£Àº ¿ÜÀΰè ÀÀ°íȰ¼ºÀ» Á¾ÇÕÀûÀ¸·Î Æ¯Á¤Çϴ °Ë»çÀÇ ÇϳªÀÌ´Ù. ÇǰËÇ÷Àå¿¡ Ä®½·À̿°ú Á¶Á÷Æ®·Òº¸ÇÃ¶ó½ºÆ¾(Á¦III ÀÀ°íÀÎÀÚ)À» °¡ÇØ, ¼¶À¯¼Ò°¡ ³ªÅ¸³¯ ¶§±îÁöÀÇ ½Ã°£À¸ ÃøÁ¤ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • data acquisition
    ÀÚ·á¼öÁý
  • acquisition time
    ȹµæ½Ã°£
  • real time acquisition
    ½Ç½Ã°£È¹µæ
  • data
    ÀÚ·á
  • data clipping
    ÀÚ·áÀý´Ü
  • data clipping artifact
    ÀÚ·áÀý´ÜÀΰø¹°
  • data display
    ÀÚ·áÇ¥½Ã
  • data processing
    ÀÚ·áó¸®
  • material safety data sheet
    ¹°Áú¾ÈÀüÀÚ·á¿ëÁö
  • acquisition
    ȹµæ, ½Àµæ
  • acquisition matrix number
    ȹµæÇà·Ä¼ö
  • acquisition method
    ȹµæ¹æ¹ý
  • gradient acquisition imaging
    ±â¿ï±âȹµæ¿µ»ó
  • gradient refocused acquisition
    ±â¿ï±âÀçÃÊÁ¡È¹µæ
  • multislice imaging acquisition
    ´ÙÁßÀýÆí¿µ»óȹµæ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquisition time
    ȹµæ½Ã°£
  • acquisition
    ȹµæ, ½Àµæ
  • data
    ÀÚ·á
  • baseline data
    ±âÃÊÀÚ·á
  • time
    ½Ã°£
  • activated partial thromboplastin time
    Ȱ¼ºÈ­ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • bleeding time
    ÃâÇ÷½Ã°£
  • clot retraction time
    ÇǶ±µÞ´ç±è½Ã°£, Ç÷º´ÅðÃà½Ã°£
  • coagulation time
    ÀÀ°í½Ã°£
  • colonic transit time
    ´ëÀåÅë°ú½Ã°£
  • diastolic filling time
    È®Àå±âÃæ¸¸½Ã°£
  • diffusion time
    È®»ê½Ã°£
  • expiratory pause time
    ³¯¼ûÈĽ¬´Â½Ã°£, È£±âÈÄÈÞÁö½Ã°£
  • expiratory phase time
    ³¯¼û½Ã°£, È£±â½Ã°£
  • exposure time
    ³ëÃâ½Ã°£, Æø·Î½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • data acquisition
    ÀÚ·á¼öÁý
  • acquisition time
    ȹµæ½Ã°£
  • real time acquisition
    ½Ç½Ã°£È¹µæ
  • data clipping artifact
    ÀÚ·áÀý´ÜÀΰø¹°
  • baseline data
    ±âÃÊÀÚ·á
  • blood gas data
    Ç÷¾×°¡½º°Ë»çÀÚ·á
  • clinical data
    ÀÓ»óÀÚ·á
  • data clipping
    ÀÚ·áÀý´Ü
  • data
    ÀÚ·á, Àç·á, µ¥ÀÌÅÍ
  • data display
    ÀÚ·áÇ¥½Ã
  • data processing
    ÀÚ·áó¸®
  • discrete data
    ÀÌ»êÀÚ·á
  • surveillance data
    °ü¸®Á¤º¸Á¶»çÀÚ·á
  • material safety data sheet
    ¹°Áú¾ÈÀüÀÚ·á¿ëÁö
  • acquisition
    ȹµæ, ½Àµæ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquisition time
    ȹµæ ½Ã°£
  • real time acquisition
    ½Ç½Ã°£ ȹµæ
  • Clinical data
    ÀÓ»óÀÚ·á
  • Data analysis
    Á¤º¸ºÐ¼®
  • MSDS => Material Safety Data Sheet
    ¹°Áú¾ÈÀüÀÚ·á¿ëÁö
  • identifying data
    ½Å»óÀÚ·á
  • CE FAST(contrast enhanced fast acquisition in the st
    ´ëÁ¶µµ Áõ°­ Ç×Á¤»óÅÂÀÇ °í¼Óȹµæ
  • FAST(Fourier acquisition in the steady state) sequen
    Ç×Á¤ »óÅ¿¡¼­ÀÇ Fourier ȹµæ ¿¬¼â
  • MOTSA (multiple overlapping thin-slab acquisition)
    ´ÙÁß Áߺ¹ ¼¼ÆíÆÇ ȹµæ
  • MP-RAGE (magnetization prepared rapid acquisition gr
    ÀÚÈ­ Áغñ °í¼Ó °æ»ç¿¡ÄÚ È¹µæ
  • acquisition
    ȹµæ
  • acquisition matrix number
    ȹµæ Çà·Ä ¼ö, ȹµæ ¸ÅÆ®¸¯½º ¼ö
  • acquisition method
    ȹµæ ¹æ¹ý
  • gradient refocused acquisition
    °æ»ç ÀçÃÊÁ¡ ȹµæ
  • huma immunodeficiency virus,fetal acquisition of
    Å»ýȹµæ(÷ÃßæüòÔð)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • data acquisition time
    ÀÚ·á ȹµæ ½Ã°£
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • data acquisition
    µ¥ÀÌÅͼöÁý
  • acquisition time
    ȹµæ ½Ã°£
  • real time acquisition
    ½Ç½Ã°£ ȹµæ
  • base line data
    ±âÃÊÀÚ·á.
  • data archiving
    µ¥ÀÌÅÍÀúÀå
  • data clipping
    ÀÚ·á Àý´Ü
  • data clipping artifact
    ÀÚ·á Àý´Ü Àΰø¹°
  • data collection
    µ¥ÀÌŸ¼öÁý
  • data display
    µ¥ÀÌÅÍÇ¥½Ã
  • data processing
    µ¥ÀÌÅÍó¸®
  • enumeration data
    °è¼ö(Ë­Ëà)µ¥ÀÌŸ.
  • epidemiological data
    ¿ªÇÐÀû ÀÚ·á.
  • identifying data
    ½Å»óÀÚ·á
  • medical data processing computer
    ÀÇ¿ë <µ¥ÀÌÅÍ󸮿ë>Àü<ÀÚ°è>»ê±â(ËöËí<ÊÙ̧ËöËí>Ëø<ËöË­>Ë×Ë»), ÀÇÇÐÀÚ·á󸮿ë ÄÄÇ»ÅÍ.
  • missing data
    °áÃøÄ¡(˭̬̬).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • assimilation time
    µ¿È­ÀÛ¿ë ½Ã°£ (ÔÒûùíÂéÄãÁÊà)
  • clotting time
    ÀÀ°í½Ã°£(ëêͳãÁÊà)
  • coincidence time
    µ¿½Ã½Ã°£(ÔÒãÁãÁÊà)
  • double beam in time spectrophotometer
    ½Ö±¤¼Ó ½Ã°£ ºÐ±¤±¤µµ°è(äªÎÃãÁÊàáÜÝÂÎÃÎÃÓøÍª)
  • elution time
    ¿ë¸® ½Ã°£ (éÁ×îãÁÊà)
  • fixed time assay
    ÀÏÁ¤½Ã°£(ìéïÒãÁÊà) ¾Æ½êÀÌ
  • generation time
    ¼¼´ë ½Ã°£(á¦ÓÛãÁÊà)
  • generation-time hypothesis
    ¼¼´ë ½Ã°£ ¼³(á¦ÓÛãÁÊààã)
  • half-reaction time
    ¹Ý¹ÝÀÀ ½Ã°£(ÚâÚãëëãÁÊà)
  • half-time
    ¹Ý ½Ã°£(ÚâãÁÊà)
  • high-temperature-short-time method
    °í¿Â ´Ü½Ã°£¹ý(ÍÔè®Ó­ãÁÊàÛö)
  • mean generation time
    Æò±Õ¼¼´ë±â°£(øÁгá¦ÓáÑ¢Êà)
  • recovery time
    ȸ¼ö ½Ã°£(üÞâ¥ãÁÊà)
  • relaxation time
    ÀÌ¿Ï ½Ã°£(ì¬èÐãÁÊà)
  • residence time
    µ¿°Å ½Ã°£(ÔÒËÜãÁÊà)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • data acquisition time
    ÀÚ·áȹµæ½Ã°£
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquisition time
    ȹµæ½Ã°£
  • real time acquisition
    ½Ç½Ã°£È¹µæ
  • data clipping
    ÀÚ·áÀý´Ü
  • data clipping artifact
    ÀÚ·áÀý´ÜÀΰø¹°
  • fiber distributed data interface(FDDI)
    ±¤³×Æ®¿öÅ©
  • multiinstitutional data
    ´Ù±â°üÀÚ·á
  • raw data
    ±âÃÊ ÀÚ·á, »ýÀÚ·á
  • acquisition
    ȹµæ, ½Àµæ
  • acquisition matrix number
    ȹµæÇà·Ä¼ö, ȹµæ¸ÅÆ®¸¯½º¼ö
  • acquisition method
    ȹµæ¹æ¹ý
  • CE FAST [=contrast enhanced fast acquisition in the steady state]
    Ç×Á¤»óÅÂÀÇ ´ëÁ¶µµÁõ°­°í¼Óȹµæ
  • FAST(Fourier acquisition in the steady state) sequence
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ¿¬¼â
  • Fourier acquisition in the steady state [=FAST]
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ
  • gradient acquisition imaging
    °æ»çȹµæ¿µ»ó
  • gradient refocused acquisition
    °æ»çÀçÃÊÁ¡È¹µæ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CT calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ...
PTT partial thromboplastin time; particle transport time; posterior tibial tendon (transfer); prothrombi...
MDS Master of Dental Surgery; maternal deprivation syndrome; medical data screening; medical data system...
a.t. acquisition time; ¿µ»óȸº¹½Ã°£
  = TR x N x Nex
  TR; Time to Repeat
 &...
DACS data acquisition and control system
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GRASS Gradient-recalled acquisition in the steady state
HASTE Half-Fourier Acquisition Single-Shot Turbo Spin Echo
MUGA Multiple gated acquisition
RARE Rapid Acquisition Relaxation Enhanced
RARE Rapid Acquisition with Relaxation Enhancement
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acquisition time
    ȹµæ ½Ã°£
  • real time acquisition
    ½Ç½Ã°£ ȹµæ
  • data processing
    ÀÚ·á ó¸®
  • digital data
    ¼öÄ¡ ÀÚ·á
  • fiber distributed data interface
    ±¤ ³×Æ®¿öÅ©
  • missing data
    °áÃøÄ¡
  • raw data
    ¿ø ÀÚ·á
  • acquisition matrix number
    ȹµæ Çà·Ä¼ö, ȹµæ ¸ÅÆ®¸¯½º ¼ö
  • Fourier acquisition in the steady state sequence
    Ç×Á¤ »óÅ¿¡¼­ÀÇ Fourier ȹµæ ¿¬¼â
  • multi echo stimulated echo acquisition
    ´ÙÁß ¿¡ÄÚ ÀÚ±Ø ¿¡ÄÚ È¸µæ
  • number of acquisition
    ȹµæ ȸ¼ö
  • stimulated echo acquisition mode
    ÀÚ±Ø ¿¡ÄÚ È¹µæ ¹æ½Ä
  • activated coagulation time
    Ȱ¼º Ç÷¾× ÀÀ°í½Ã°£
  • area under the concentration-time curve
    Ç÷Áß ³óµµ °î¼±ÇÏ ¸éÀû, Ç÷Áß ¾à¹° ³óµµ °î¼±ÇÏ ¸éÀû
  • arm to lung time test
    ÆÈ Æó ¼øÈ¯ ½Ã°£ ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acquisition In psychology, the empirical demonstration of an increase in the strength of the conditioned response in successive trials of pairing the conditioned and unconditioned stimulus.
(05 Mar 2000)
automatic data processing Data processing largely performed by automatic means.
(12 Dec 1998)
Physicians Data Query <oncology> A free enquiry service originating in the USA for physicians on all state of the art cancer diagnostic, preventive and treatment methods.
The documents are provided by the US National Cancer Institute and includes electronic access of various forms.
WWW: CancerNET
Acronym: PDQ
(12 Jan 1998)
molecular sequence data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as genbank, european molecular biology laboratory (embl), national biomedical research foundation (nbrf), or other sequence repositories.
(12 Dec 1998)
national practitioner data bank A databank established by the health care quality improvement act of 1986 authorizing the department of health and human services to collect and release information on the professional competence and conduct of physicians, dentists, nurses, and other health care practitioners. The data include adverse actions on physicians' malpractice, licensure, hospital privileges, concealing of pertinent information, and the like.
(12 Dec 1998)
subjective assessment data Those facts that are observable and measurable by the nurse.
(05 Mar 2000)
data Multiple facts (usually but not necessarily empirical) used as a basis for inference, testing, models, etc. The word is plural and takes a plural verb.
(05 Mar 2000)
data collection Systematic gathering of data for a particular purpose from various sources, including questionnaires, interviews, observation, existing records, and electronic devices. The process is usually preliminary to statistical analysis of the data.
(12 Dec 1998)
data display The visual display of data in a man-machine system. An example is a cathode ray tube display in which certain data can be called for from the computer and presented on the screen.
(12 Dec 1998)
data interpretation, statistical Application of statistical procedures to analyze specific observed or assumed facts from a particular study.
(12 Dec 1998)
data processing Conversion of crude information into usable or storable form; statistical analysis of data by a computer program.
(05 Mar 2000)
objective assessment data Those facts presented by the client that show his/her perception, understanding and interpretation of what is happening.
(05 Mar 2000)
activated clotting time The most common test used for coagulation time in cardiovascular surgery.
(05 Mar 2000)
activated partial thromboplastin time The time needed for plasma to form a fibrin clot following the addition of calcium and a phospholipid reagent; used to evaluate the intrinsic clotting system.
(05 Mar 2000)
A-H conduction time Forward conduction of the cardiac impulse from atria to ventricles via the A-V node or any bypass tract, represented in the electrocardiogram by the P-R interval. P-H conduction time is from the onset of the P wave to the first high frequency component of the His bundle electrogram (normally 119 &plusmn; 38 msec); A-H conduction time is from the onset of the first high frequency component of the atrial electrogram to the first high frequency component of the His bundle electrogram (normally 92 &plusmn; 38 msec); P-A conduction time is from the onset of the P wave to the onset of the atrial electrogram (normally 27 &plusmn; 18 msec).
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • data acquisition
    (Àü»ê)µ¥ÀÌÅÍ ¼öÁý
  • acquisition
    ½Àµæ
  • acquisition
    Ãëµæ;ȹµæ;Ãëµæ¹°;ȹµæ¹°
  • perimeter acquisition radar
    ÁÖº¯ Æ÷Âø ·¹ÀÌ´õ
  • automatic data processing
    ÀÚµ¿ Á¤º¸ ó¸®
  • data
    Àç·á;ÀÚ·á;µ¥ÀÌÅÍ
  • data bank
    µ¥ÀÌÅ͹ðÅ©¿¡ ³Ö´Ù(º¸°üÇÏ´Ù)
  • data bank
    µ¥ÀÌÅÍ ¹ðÅ©(ÀüÀÚ °è»ê±â¿ë Á¤º¸¿Í ±× ÃàÀû º¸°ü ¹× Á¦°ø ±â°ü) ?,
  • data base
    µ¥ÀÌÅͺ£À̽º(ÀüÀÚ°è»ê±â¿ë Á¤º¸ÀÇ ÃàÀû ¹× ÀÌ Á¤º¸ÀÇ Á¦°ø ¼­ºñ½º)
  • data base management system
    (Àü»ê)µ¥ÀÌÅͺ£À̽º °ü¸® ½Ã½ºÅÛ(¾à DBMS)
  • data binder
    (Àü»ê)µ¥ÀÌÅÍ ¹ÙÀδõ(ÄÄÇ»ÅͷκÎÅÍÀÇ ÇÁ¸°Æ®¾Æ¿ôÀ» öÇÏ´Â)
  • data broadcasting
    µ¥ÀÌÅÍ ºê·Îµåij½ºÆÃ(°¢Á¾ µ¥ÀÌÅ͸¦ Àü¼ÛÇÏ´Â µîÀÇ »õ·Î¿î ¹æ¼Û ¼­ºñ½º ¹æ½Ä)
  • data capture collection
    (Àü»ê)(´Ü¸»ÀåÄ¡·ÎºÎÅÍÀÇ)µ¥ÀÌÅÍ ¼öÁý
  • data communication
    µ¥ÀÌÅÍ Åë½Å
  • data encryption standard
    µ¥ÀÌÅÍ ¾Ïȣȭ ±âÁØ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á